Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
bayer
5
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
5
×
detroit blog main
5
×
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
5
×
raleigh-durham blog main
raleigh-durham top stories
5
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
5
×
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biotech
cancer immunotherapy
gilead sciences
merck
nonalcoholic steatohepatitis
startups
astrazeneca
fda
gene therapy
genfit
What
bio
roundup
drug
pfizer’s
amid
bombast
cancer
caught
coronavirus
debate
develop
discussion
efforts
meso’s
miss
nash
news
pandemic
presidential
promise
response
tuesday’s
vaccine
viewers
acquisitions
aducanumab
albert
alzheimer’s
amyloid
angst
approved
bagged
biggest
billions
biogen
biogen’s
bourla
brammer
ceo
companies
Language
unset
unknown
Current search:
bayer
×
deals
×
" texas blog main "
×
pfizer
×
" raleigh-durham top stories "
×
" detroit blog main "
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More